Your browser doesn't support javascript.
Elevated Serum Levels of MCP-1 and IP-10 Chemokines in Patients with COVID-19 Infection
NeuroQuantology ; 20(6):6769-6779, 2022.
Article in English | EMBASE | ID: covidwho-1939461
ABSTRACT

Background:

There are little researches taken discussed the effect of IP-10 and MCP-1 in the coronavirus infection. Therefore, our study mainly aims to estimate whether IP-10 and MCP-1 is associated to disease severity in a samples of Iraqi patients with COVID-19.

Methods:

The Cross-sectional study included 90 patients infected with covid-19 virus divided in to (45) with severe infection and (45) with mild infection,51 males and 39 females. Serum levels of MCP-1 and IP-10 was measured by sandwich ELISA test.

Results:

MCP-1 chemokine in severe COVID-19 patients was significantly higher (P=0.000) than in mild patients. Also, IP-10 chemokine showing a higher significant association (P =0.025) with severe patients group. There is a highly significant difference of Oxygen saturation in the distribution of mild and severe patients (P= 0.000). The Computed Tomography, Ferritin and D.dimer showing a higher significant association with severe patients (P=0.000) compared with mild patients.

Conclusion:

According to the current study the serum levels of Interferon Gamma Induced Protein 10 (IP-10) and Monocyte Chemotactic Protein 1 (MCP-1) showing a significant association with the severe COVID-19 infections.
Keywords

Full text: Available Collection: Databases of international organizations Database: EMBASE Language: English Journal: NeuroQuantology Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: EMBASE Language: English Journal: NeuroQuantology Year: 2022 Document Type: Article